Hyperprolactinemia: Clinical Trials

1 trial for Hyperprolactinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on Bioequivalence of Cabergoline Tablets in Human Body
Cabergoline tablets test formulation, Cabergoline tablets reference formulation - Hyperprolactinemia
Phase 1Active not recruitingChangchun GeneScience Pharmaceutical Co., Ltd.722025-06-302025-11-17

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Hyperpituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Nervous System Diseases (1)  ·  Pituitary Diseases (1)

Interventions

Cabergoline (1)

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd. (1)

Countries

China (1)